Autoimmunity during alpha-interferon therapy for chronic hepatitis C
- PMID: 8359620
- DOI: 10.1007/BF02989219
Autoimmunity during alpha-interferon therapy for chronic hepatitis C
Abstract
One hundred twenty-five patients with chronic hepatitis C were treated with natural IFN alpha or recombinant IFN alpha-2a, daily doses of 3 MU or 9 MU, respectively. IFNs were given 6 times a week for the first 2 weeks followed by thrice weekly administration for 12 weeks or more. ANA, TMA, AMA and anti-DNA antibody newly developed in 8, 1, 2 and 1 patient, respectively. Furthermore, we encountered some cases in which underlying autoimmune disorders were thought to be exacerbated by IFNs. It is important to pay sufficient attention to the development of autoimmune diseases in IFN therapy for chronic hepatitis C.
Similar articles
-
Interferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation.Hepatogastroenterology. 1995 Nov-Dec;42(6):900-6. Hepatogastroenterology. 1995. PMID: 8847043 Clinical Trial.
-
[Autoimmune biological anomalies in 35 patients with chronic viral hepatitis C treated over 6 months with interferon and followed-up over a year].Rev Med Interne. 1993;14(10):1009. doi: 10.1016/s0248-8663(05)80127-4. Rev Med Interne. 1993. PMID: 8009007 French.
-
Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.Am J Nephrol. 1996;16(6):478-83. doi: 10.1159/000169047. Am J Nephrol. 1996. PMID: 8955758
-
Exacerbation of primary biliary cirrhosis during interferon-alpha 2b therapy for chronic active hepatitis C.Dig Dis Sci. 1995 Jun;40(6):1226-30. doi: 10.1007/BF02065528. Dig Dis Sci. 1995. PMID: 7781437 Review.
-
[Anti-platelet antibody and severe thrombocytopenia during interferon-alpha therapy for chronic active hepatitis C].Nihon Rinsho Meneki Gakkai Kaishi. 1996 Apr;19(2):150-6. doi: 10.2177/jsci.19.150. Nihon Rinsho Meneki Gakkai Kaishi. 1996. PMID: 8705692 Review. Japanese.
Cited by
-
Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis.Drugs. 1995 Nov;50(5):873-96. doi: 10.2165/00003495-199550050-00007. Drugs. 1995. PMID: 8586031 Review.
-
Autoimmune hepatitis and thyroiditis associated with rifampin and pyrazinamide prophylaxis: an unusual reaction.Dig Dis Sci. 2005 Jan;50(1):207-11. doi: 10.1007/s10620-005-1302-0. Dig Dis Sci. 2005. PMID: 15712662 No abstract available.
-
[Interferon therapy and autoimmunity].Med Klin (Munich). 1997 May 15;92(5):265-72. doi: 10.1007/BF03045081. Med Klin (Munich). 1997. PMID: 9244832 Review. German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials